TIA DAWES: Open Payments
NPI 1487061305 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 22 payments from 7 companies in 2025. Trend: 2023 $555 · 2024 $409 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $146 |
| Lilly USA, LLC | 1 | $106 |
| PFIZER INC. | 4 | $65 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: ZEPBOUND, VRAYLAR, GEMTESA, UBRELVY, PREVNAR 20, NURTEC ODT, QULIPTA, SHINGRIX.
Industry payments across PA — which companies pay providers there.
